当前位置:首页 - 行情中心 - 德展健康(000813) - 财务分析 - 现金流量表

德展健康

(000813)

  

流通市值:58.08亿  总市值:58.09亿
流通股本:20.97亿   总股本:20.97亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金191,749,208.66128,268,207.1480,060,929.88421,198,891.67
  收到的税费返还7,956,720.85721.99-513,044.82
  收到其他与经营活动有关的现金93,180,691.1541,827,756.2539,785,923.4154,572,563.43
  经营活动现金流入小计292,886,620.66170,096,685.38119,846,853.29476,284,499.92
  购买商品、接受劳务支付的现金28,162,268.9118,945,977.398,320,540.467,313,202.24
  支付给职工以及为职工支付的现金169,853,714.67118,694,291.0559,296,808.5232,606,269.85
  支付的各项税费31,907,400.4126,026,416.511,159,079.3462,880,229.56
  支付其他与经营活动有关的现金89,077,313.8158,723,894.2224,983,955.56108,762,315.15
  经营活动现金流出小计319,000,697.8222,390,579.16103,760,383.8471,562,016.8
  经营活动产生的现金流量净额-26,114,077.14-52,293,893.7816,086,469.494,722,483.12
二、投资活动产生的现金流量:
  收回投资收到的现金6,000,0006,000,0003,000,00010,000,000
  取得投资收益收到的现金00-35,101.19
  处置固定资产、无形资产和其他长期资产收回的现金净额1,046,582.48393,175303,665577,987.66
  投资活动现金流入小计7,046,582.486,393,1753,303,66510,613,088.85
  购建固定资产、无形资产和其他长期资产支付的现金142,784,186.23115,439,130.6480,838,187.75235,988,546.05
  投资支付的现金904,000,000300,000,000300,000,000460,000,000
  投资活动现金流出小计1,046,784,186.23415,439,130.64380,838,187.75695,988,546.05
  投资活动产生的现金流量净额-1,039,737,603.75-409,045,955.64-377,534,522.75-685,375,457.2
三、筹资活动产生的现金流量:
  吸收投资收到的现金0004,000,000
  其中:子公司吸收少数股东投资收到的现金---4,000,000
  取得借款收到的现金000114,800,000
  筹资活动现金流入小计000118,800,000
  偿还债务支付的现金500,000500,000500,0002,368,571.42
  分配股利、利润或偿付利息支付的现金1,691,121.241,124,017.91556,914.581,481,244.51
  支付其他与筹资活动有关的现金5,922,061.353,103,493.431,254,380.88135,746,711.96
  筹资活动现金流出小计8,113,182.594,727,511.342,311,295.46139,596,527.89
  筹资活动产生的现金流量净额-8,113,182.59-4,727,511.34-2,311,295.46-20,796,527.89
四、汇率变动对现金及现金等价物的影响00070.93
五、现金及现金等价物净增加额-1,073,964,863.48-466,067,360.76-363,759,348.72-701,449,431.04
  加:期初现金及现金等价物余额1,756,129,111.091,756,129,111.091,756,129,111.092,457,578,542.13
  期末现金及现金等价物余额682,164,247.611,290,061,750.331,392,369,762.371,756,129,111.09
补充资料:
  净利润--75,307,710.7--421,925,827.96
  资产减值准备-3,178,189.5-179,756,793.34
  固定资产和投资性房地产折旧-32,724,289.55-63,524,228.41
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-32,724,289.55-63,524,228.41
  无形资产摊销-6,849,139.37-20,521,007.66
  长期待摊费用摊销-9,679,949.47-18,266,939.23
  处置固定资产、无形资产和其他长期资产的损失-8,635.4--1,378,451.21
  固定资产报废损失-412,864.02-85,100.06
  公允价值变动损失--46,935.06--81,338.21
  财务费用-1,311,539.78-29,998,457.29
  投资损失-1,427,611.6-27,869,182.51
  递延所得税-997,502.29--2,672,867.9
  其中:递延所得税资产减少-1,797,858.05-9,418,990.96
    递延所得税负债增加--800,355.76--12,091,858.86
  存货的减少-12,473,170.41-42,277,219.26
  经营性应收项目的减少--27,382,908.68--6,657,452.74
  经营性应付项目的增加--34,130,760.67--6,201,594.76
  债务转为资本---0
  一年内到期的可转换公司债券---0
  融资租入固定资产---0
  现金的期末余额-1,290,061,750.33-1,756,129,111.09
  减:现金的期初余额-1,756,129,111.09-2,457,578,542.13
  加:现金等价物的期末余额---0
  减:现金等价物的期初余额---0
  现金及现金等价物的净增加额--466,067,360.76--701,449,431.04
公告日期2026-10-302026-08-292026-04-252026-04-25
审计意见(境内)标准无保留意见
TOP↑